Evidence map›Paper›PMID 37809632›Full record

ArticleHeliyon2023

Shiga toxin 2 A-subunit induces mitochondrial damage, mitophagy and apoptosis via the interaction of Tom20 in Caco-2 cells.

Jie Tang, Xiaoxue Lu, Tao Zhang, Yuyang Feng, Qiaolin Xu, Jing Li, Yuanzhi Lan, Huaxing Luo, Linghai Zeng, Yuanyuan Xiang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Jie TangDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Xiaoxue LuDepartment of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Tao ZhangDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Yuyang FengDepartment of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Qiaolin XuDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Jing LiDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Yuanzhi LanDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Huaxing LuoDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Linghai ZengDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Yuanyuan XiangDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Yan ZhangDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Qian LiDepartment of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Xuhu MaoDepartment of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Bin TangDepartment of Clinical Laboratory, Chongqing University Jiangjin Hospital, School of Medicine, Chongqing University, Jiangjin, Chongqing, 402260, China.
Dongzhu ZengDepartment of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Chongqing Medical University · CNArmy Medical University · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin type 2 (Stx2) is the primary virulence factor produced by Shiga toxin-producing enterohemorrhagic

Indexed as

ApoptosisMitophagyShiga toxinShiga toxin type 2Tom20

Identifiers

PMID37809632
PMCPMC10559750
OpenAlexW4386566025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.